Revolution Medicines, Inc. officer Jack Lee Anders filed a Form 144 notice on November 12, 2026, proposing the sale of 35,750 shares of common stock acquired through stock option exercise on November 11, 2026.
Intercontinental Exchange Inc. officer Mayur Kapani filed a Form 144 notice of proposed sale of 4,272 shares of common stock, with the notice dated November 11, 2026 and submitted to the SEC on November 12, 2026.
Gabriel Mecklenburg, Executive Chairman and Co-Founder of Hinge Health, Inc., filed a Form 144 notice on November 12, 2026, disclosing a proposed sale of 200,000 shares of Hinge Health common stock on NYSE.
Director Atul Pande filed a Form 144 notice of proposed sale with the SEC on November 12, 2026, covering 6,000 shares of Immunovant, Inc. common stock acquired through a stock option exercise on November 11, 2026.
Palantir Technologies Inc. officer Shyam Sankar filed a Form 144 notice on November 12, 2026, disclosing a proposed sale of 84,680 shares of common stock with an aggregate market value of $14,295,677.60, to be executed through a Rule 10b5-1 plan.
Andrew Hardy, an officer of NXP Semiconductors N.V., filed a Form 144 notice of proposed sale of 1,643 shares of common stock on November 11, 2026, with the filing submitted to the SEC on November 12, 2026.
Director Maura Markus filed a Form 144 Notice of Proposed Sale of Securities with the SEC on November 12, 2026, disclosing a plan to sell 3,180 shares of Broadridge Financial Solutions, Inc. common stock acquired through a stock option exercise on November 11, 2026.
Fair Isaac & Co Inc officer and director William J. Lansing filed a Form 144 notice of proposed sale on November 12, 2026, covering 9,782 shares of common stock acquired through a stock option exercise on November 11, 2026.
Stephen Gerard Daly, a director and officer of MACOM Technology Solutions Holdings, filed a Form 144 on November 12, 2026, providing notice of a proposed sale of 59,939 shares of common stock, with the sale executed on November 11, 2026.
BETA Technologies, Inc. officer Sean Donovan filed a Form 144 notice of proposed sale of 6,684 shares of common stock, with the filing submitted on November 12, 2026, covering a sale executed on November 11, 2026.